Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro

In this study, we aimed to evaluate the anticancer effect of benzimidazole derivatives on triple-negative breast cancer (TNBC) and investigate its underlying mechanism of action. Several types of cancer and normal breast cells including MDA-MB-231, radiotherapy-resistant (RT-R) MDA-MB-231, and allog...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hoon Sik, Ko, Young Shin, Jin, Hana, Kang, Ki Mun, Ha, In Bong, Jeong, Hojin, Song, Haa-Na, Kim, Hye Jung, Jeong, Bae Kwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433818/
https://www.ncbi.nlm.nih.gov/pubmed/34500557
http://dx.doi.org/10.3390/molecules26175118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433818/
https://www.ncbi.nlm.nih.gov/pubmed/34500557
http://dx.doi.org/10.3390/molecules26175118

Ejemplares similares